Introducing AI into the pharma supply chain is a journey
The proliferation of Artificial Intelligence (AI) in our lives has set about a true revolution in how we collect, organize…
Partner Content
-
-
ePRO and eCOA: Digital solutions driving clinical trials engagement
Recruiting enough participants and keeping them engaged through lengthy clinical trials is increasingly challenging. In fact, more than 80% of…
-
The impact of drug pricing and reimbursement on the pharmaceutical industry
A recent survey for GlobalData’s “State of the Biopharmaceutical Industry 2025” report, conducted at the end of 2024, found drug…
-
4x the Performance, Zero Compromise: How Functionalized Polymers Are Changing the Rules
In the race to decarbonize the global economy, advanced materials are no longer a luxury - they're a necessity. The…
-
How 3PL providers are gearing up for the wave of cell and gene therapies
The global cell and gene therapy (CGT) market is expanding at a rapid rate, and will be worth $76bn by…
-
How the cell and gene therapy market is taking shape
Cell and gene therapy (C>) represents a major advance in medical treatments by directly targeting the root causes of diseases…
-
Obesity therapies and the multi-indication momentum: how industry is responding
The obesity therapeutics market has gone from a standing start to the story of the year in biopharmaceuticals - and…
-
Overcoming cold-chain logistical challenges when delivering life-saving MS therapies
With the MS Trust estimating that more than 2.9 million people worldwide have multiple sclerosis (MS), new therapies are urgently…
-
Navigating new EU regulations in the clinical supply chain
The latest EU clinical trial regulations must be carefully understood. The Clinical Trial Regulation (CTR) was introduced in the EU…
-
London Biotechnology Show Makes Grand Return to Unveil Cutting-edge Advances in Health & Medicine
The inaugural London Biotechnology Show was a major hit with over 3,000 attendees present at the event, including representatives from…